- Mammalian Based,
- Microbial Based,
- Insect Based,
- Plant Based,
- Yeast Based,
- Others
Biopharmaceutical contract manufacturing market size was valued at USD 16.2 billion in 2022 and is expected to reach USD 23.57 billion by 2029 at a CAGR of 5.5% from 2023 to 2029. Biopharmaceuticals are also known as biologics. Biopharmaceutical products are pharmaceutical drugs that are synthesized, processed, or extracted from biological sources. Biopharmaceuticals include vaccines, blood products, recombinant therapeutic proteins, allergens, gene therapies, tissues, and living cells used in cell therapy. Many companies outsource the manufacturing of biopharmaceuticals due to a lack of manufacturing capabilities or in order to reduce the cost of the manufacturing process.
Contract manufacturing organizations offer a wide range of services such as cell line development, process optimization, fermentation biotechnology, analytical characterization, cGMP manufacturing, and validation in each stage of clinical development and commercialization. Furthermore, to meet the demand for biological products, companies are outsourcing biopharmaceutical manufacturing to various contract manufacturing companies. However, high cost associated with manufacturing and stringent regulatory requirements are expected to hamper the growth of the biopharmaceutical contract manufacturing market. The market is highly competitive where the speed to market is imperative along with efficient processes and low costs. Biopharmaceutical contract manufacturing services providers are increasing their service offerings such as formulation, production, and analytical services apart from conventional services to provide complete support for biopharmaceutical companies. Cost considerations and quick services are expected to continue to drive the outsourcing of the global biopharmaceutical contract manufacturing market.
Biopharmaceutical Contract Manufacturing Market Key Developments:
- In May 2017, Lonza Group Ltd. acquired cell and gene contract manufacturer PharmaCell B.V., this acquisition broadens Lonza's capabilities in Europe region. Companies expand their manufacturing facilities to increase market share.
- In May 2017, Boehringer Ingelheim GmbH started a new manufacturing facility in China to increase its manufacturing capacity. Through this facility company's manufacturing capacity will increase by one-third.
Global Biopharmaceutical Contract Manufacturing Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
5.5%
Largest Market
North America
Fastest Growing Market
North America
Biopharmaceutical Contract Manufacturing Market Dynamics
Biopharmaceutical contract manufacturing market is mainly driven by increase in investment of the pharma and biotechnological companies to develop and commercialize the biotechnological products. In addition, high revenue generation of blockbuster biological drugs such as humira, rituxan, lantus, avastin, herceptin and remicade are gaining traction from many biologicsmanufacturers. Advancements in the biotechnology such as recombinant DNA technologies and targeted drug therapies are expected to bolster the biopharmaceutical contract manufacturing market over the forecast period.
North-America Got Significant Share of
Biopharmaceutical Contract Manufacturing Market Regional Analysis
Geographically global biopharmaceutical contract manufacturing market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America and Europe are expected to be leading in biopharmaceutical contract manufacturing owing to increased approvals of biosimilars and increase in biopharmaceutical research organization which are lack of manufacturing facilities. In Asia-Pacific region, emerging countries such as China and India expected to grow at a rapid rate owing to low cost of manufacturing. Development of biologics pipeline by domestic companies expected to drive the growth of biopharmaceutical contract manufacturing in China.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Global Biopharmaceutical Contract Manufacturing Market Segmentation
By Manufacturing Process
By Type Of Service
- Formulation,
- Fill and Finish Services,
- Cell Banking,
- Analytical Services,
- Process development,
- Others
By Molecule Type
- Large Molecules,
- Small Molecules
By End-User
- Biopharmaceutical Companies,
- Pharmaceutical Companies,
- Research Organizations,
- Others
Frequently Asked Questions
The biopharmaceutical contract manufacturing market key players are: Lonza Group Ltd. (Switzerland), Boehringer Ingelheim GmbH (Germany), Charles River Laboratories, Inc. (U.S), Novartis AG (Switzerland), WuXi AppTec Group (China),Rentschler Biotechnologie GmbH (Germany), Fujifilm Holdings Corporation (Japan), Celonic AG (Switzerland), BIOMEVA GmbH (Germany), ProBioGen AG (Germany)
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
The key segments covered in the biopharmaceutical contract manufacturing market are, by manufacturing process, type of service, molecule type, and end-users.
| 1.Executive Summary |
| 2.Global Biopharmaceutical Contract Manufacturing Market Introduction |
| 2.1.Global Biopharmaceutical Contract Manufacturing Market - Taxonomy |
| 2.2.Global Biopharmaceutical Contract Manufacturing Market - Definitions |
| 2.2.1. Manufacturing Process |
| 2.2.2.Type Of Service |
| 2.2.3.Molecule Type |
| 2.2.4.End-User |
| 2.2.5.Region |
| 3.Global Biopharmaceutical Contract Manufacturing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Biopharmaceutical Contract Manufacturing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Biopharmaceutical Contract Manufacturing Market By Manufacturing Process, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Mammalian Based, |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Microbial Based, |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Insect Based, |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Plant Based, |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Yeast Based, |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Others |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6.Global Biopharmaceutical Contract Manufacturing Market By Type Of Service, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Formulation, |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Fill and Finish Services, |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Cell Banking, |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Analytical Services, |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Process development, |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Others |
| 6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Others (Agrochemicals, Pharmaceuticals, and Automotive)) |
| 6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 7.Global Biopharmaceutical Contract Manufacturing Market By Molecule Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Large Molecules, |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Small Molecules |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8.Global Biopharmaceutical Contract Manufacturing Market By End-User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Biopharmaceutical Companies, |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Pharmaceutical Companies, |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Research Organizations, |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9.Global Biopharmaceutical Contract Manufacturing Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Biopharmaceutical Contract Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Manufacturing Process Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Mammalian Based, |
| 10.1.2.Microbial Based, |
| 10.1.3.Insect Based, |
| 10.1.4.Plant Based, |
| 10.1.5.Yeast Based, |
| 10.1.6.Others |
| 10.2. Type Of Service Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Formulation, |
| 10.2.2.Fill and Finish Services, |
| 10.2.3.Cell Banking, |
| 10.2.4.Analytical Services, |
| 10.2.5.Process development, |
| 10.2.6.Others |
| 10.2.7.Others (Agrochemicals, Pharmaceuticals, and Automotive)) |
| 10.3. Molecule Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Large Molecules, |
| 10.3.2.Small Molecules |
| 10.4. End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Biopharmaceutical Companies, |
| 10.4.2.Pharmaceutical Companies, |
| 10.4.3.Research Organizations, |
| 10.4.4.Others |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Biopharmaceutical Contract Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Manufacturing Process Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Mammalian Based, |
| 11.1.2.Microbial Based, |
| 11.1.3.Insect Based, |
| 11.1.4.Plant Based, |
| 11.1.5.Yeast Based, |
| 11.1.6.Others |
| 11.2. Type Of Service Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Formulation, |
| 11.2.2.Fill and Finish Services, |
| 11.2.3.Cell Banking, |
| 11.2.4.Analytical Services, |
| 11.2.5.Process development, |
| 11.2.6.Others |
| 11.2.7.Others (Agrochemicals, Pharmaceuticals, and Automotive)) |
| 11.3. Molecule Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Large Molecules, |
| 11.3.2.Small Molecules |
| 11.4. End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Biopharmaceutical Companies, |
| 11.4.2.Pharmaceutical Companies, |
| 11.4.3.Research Organizations, |
| 11.4.4.Others |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 12.Asia Pacific (APAC) Biopharmaceutical Contract Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Manufacturing Process Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Mammalian Based, |
| 12.1.2.Microbial Based, |
| 12.1.3.Insect Based, |
| 12.1.4.Plant Based, |
| 12.1.5.Yeast Based, |
| 12.1.6.Others |
| 12.2. Type Of Service Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Formulation, |
| 12.2.2.Fill and Finish Services, |
| 12.2.3.Cell Banking, |
| 12.2.4.Analytical Services, |
| 12.2.5.Process development, |
| 12.2.6.Others |
| 12.2.7.Others (Agrochemicals, Pharmaceuticals, and Automotive)) |
| 12.3. Molecule Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Large Molecules, |
| 12.3.2.Small Molecules |
| 12.4. End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Biopharmaceutical Companies, |
| 12.4.2.Pharmaceutical Companies, |
| 12.4.3.Research Organizations, |
| 12.4.4.Others |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Biopharmaceutical Contract Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Manufacturing Process Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Mammalian Based, |
| 13.1.2.Microbial Based, |
| 13.1.3.Insect Based, |
| 13.1.4.Plant Based, |
| 13.1.5.Yeast Based, |
| 13.1.6.Others |
| 13.2. Type Of Service Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Formulation, |
| 13.2.2.Fill and Finish Services, |
| 13.2.3.Cell Banking, |
| 13.2.4.Analytical Services, |
| 13.2.5.Process development, |
| 13.2.6.Others |
| 13.2.7.Others (Agrochemicals, Pharmaceuticals, and Automotive)) |
| 13.3. Molecule Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Large Molecules, |
| 13.3.2.Small Molecules |
| 13.4. End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Biopharmaceutical Companies, |
| 13.4.2.Pharmaceutical Companies, |
| 13.4.3.Research Organizations, |
| 13.4.4.Others |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Biopharmaceutical Contract Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Manufacturing Process Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Mammalian Based, |
| 14.1.2.Microbial Based, |
| 14.1.3.Insect Based, |
| 14.1.4.Plant Based, |
| 14.1.5.Yeast Based, |
| 14.1.6.Others |
| 14.2. Type Of Service Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Formulation, |
| 14.2.2.Fill and Finish Services, |
| 14.2.3.Cell Banking, |
| 14.2.4.Analytical Services, |
| 14.2.5.Process development, |
| 14.2.6.Others |
| 14.2.7.Others (Agrochemicals, Pharmaceuticals, and Automotive)) |
| 14.3. Molecule Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Large Molecules, |
| 14.3.2.Small Molecules |
| 14.4. End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Biopharmaceutical Companies, |
| 14.4.2.Pharmaceutical Companies, |
| 14.4.3.Research Organizations, |
| 14.4.4.Others |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Lonza Group Ltd. (Switzerland) |
| 15.2.2.Boehringer Ingelheim GmbH (Germany) |
| 15.2.3.Charles River Laboratories, Inc. (U.S) |
| 15.2.4.Novartis AG (Switzerland) |
| 15.2.5.WuXi AppTec Group (China) |
| 15.2.6.Rentschler Biotechnologie GmbH (Germany) |
| 15.2.7.Fujifilm Holdings Corporation (Japan) |
| 15.2.8.Celonic AG (Switzerland) |
| 15.2.9.BIOMEVA GmbH (Germany) |
| 15.2.10.ProBioGen AG (Germany) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Lonza Group Ltd. (Switzerland)
- Boehringer Ingelheim GmbH (Germany)
- Charles River Laboratories, Inc. (U.S)
- Novartis AG (Switzerland)
- WuXi AppTec Group (China)
- Rentschler Biotechnologie GmbH (Germany)
- Fujifilm Holdings Corporation (Japan)
- Celonic AG (Switzerland)
- BIOMEVA GmbH (Germany)
- ProBioGen AG (Germany)